Nurix Therapeutics, Inc.
SEC CIK 1549595 · NRIX · last insider filing 2026-06-25
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Gregory Julia P | Director | filed 2020 - 2026 |
| Reinsdorf Judith A | Director | filed 2021 - 2026 |
| Silva Paul M | Director | filed 2021 - 2026 |
| Baynes Roy D. | Director | filed 2025 - 2026 |
| Kapur Anil | Director | filed 2024 - 2026 |
| Lacey David L. | Director | filed 2020 - 2026 |
| Dansey Roger D | Director | filed 2025 - 2026 |
| Saltzman Edward C | Director | filed 2022 - 2026 |
| Sands Arthur T | Director · President, CEO | filed 2020 - 2026 |
| Kunkel Lori Anne | Director | filed 2020 - 2025 |
| Siegall Clay B | Director | filed 2021 - 2022 |
| Tong Jeffrey K | Director | filed 2020 - 2021 |
| Chen Leon | Director | filed 2020 - 2021 |
| Goeddel David V | Director | filed 2020 - 2021 |
| Tjian Robert | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Hansen Gwenn | Chief Scientific Officer | filed 2020 - 2026 |
| Ring Christine | General Counsel | filed 2020 - 2026 |
| van Houte Hans | Chief Financial Officer | filed 2020 - 2026 |
| Wolff Stefani | EVP and COO | filed 2021 - 2023 |
| Beaurang Pierre | Chief Business Officer | filed 2020 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.